Lymphokine production by T-cell clones after human bone marrow transplantation

A. Velardi, P. Varese, A. Terenzi, C. Dembech, N. Albi, C. E. Grossi, L. Moretta, M. F. Martelli, F. Grignani, M. C. Mingari

Research output: Contribution to journalArticle

Abstract

T cells recovering after bone marrow transplantation (BMT) were analyzed for their phenotypic and functional features by two-color immunofluorescence and a high efficiency cloning technique. A predominance of cells co-expressing natural killer (NK)-related surface antigens, such as Leu 7 (CD57) and CD11b, was detected with both the CD4+ and CD8+ subsets from 5 months postgrafting onward. Such cells are virtually absent among normal circulating CD4+ cells and account for a minority (~30%) of normal CD8+ cells. Postgrafting T cells representative of the whole range of NK-related antigen co-expression were selected from six patients for clonal analyses. In control subjects, 63% and 41% of the CD4+ and CD8+ clones, respectively, produced interleukin-2 (IL-2) whereas ~30% of either CD4+ or CD8+ control clones produced interferon (IFN)-gamma. At variance, and irrespective of their CD4+/CD8+ phenotype, lower proportions of BMT recipient-derived clones produced IL-2 (20% and 12%, respectively), whereas the majority of both CD4+ and CD8+ clones (75% and 71%, respectively) released high amounts of IFN-gamma. Purified populations of CD57+/CD11b+ v negative cells from two BMT recipients and two control subjects were cloned and subsequently evaluated for IL-2 and IFN-gamma production. CD57+/CD11b cell-derived clones were poor IL-2 producers in both normal subjects and BMT patients. In contrast, IL-2-producing clones were frequent (62% to 79%) among those derived from CD57-/CD11b- cells from normal subjects, whereas they were still represented at lower than normal proportions, ie, 25% to 41%, among clones generated from BMT recipients. CD57+/CD11b+ cells gave rise to comparably high proportions of IFN-gamma producing clones in both normal subjects and BMT recipients (~80%). In contrast, IFN-gamma producing clones were ~25% to 50% of CD57-/CD11b- cell-derived clones in both normal subjects and BMT patients. Therefore, while the predominance of NK-related antigen-positive T cells may be predictive of poor IL-2 and high IFN-gamma production, the immune derangement in long-term BMT recipients is further enhanced by the finding that all T cells may be poor IL-2 producers. It is also suggested that IL-2 production is a preferential function of T cells that do not express CD57 and CD11b, whereas IFN-gamma production is attributable to T cells that express CD57 and CD11b.

Original languageEnglish
Pages (from-to)1665-1672
Number of pages8
JournalBlood
Volume74
Issue number5
Publication statusPublished - 1989

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Lymphokine production by T-cell clones after human bone marrow transplantation'. Together they form a unique fingerprint.

  • Cite this

    Velardi, A., Varese, P., Terenzi, A., Dembech, C., Albi, N., Grossi, C. E., Moretta, L., Martelli, M. F., Grignani, F., & Mingari, M. C. (1989). Lymphokine production by T-cell clones after human bone marrow transplantation. Blood, 74(5), 1665-1672.